Brief Title
Use of Robotics for Cholecystectomy; Retrospective Review of Outcomes, Set Up and Learning Curves
Official Title
Evolution of Robotic Cholecystectomy; the U.C. Davis Experience.
Brief Summary
Comparing the use of surgical robotics during a Cholecystectomy, comparing different platforms and approaches (multi port verses single port).
Detailed Description
This study is a restrospective review of charts, including operating room notes as well as operating room documentation of procedures. Currently there are numerous methods considered to be the Standard of Care in the surgical treatment of Cholecystitis, or Cholelithiasis, including Open Surgery, Laparoscopic, and Robotic Assisted Laparoscopic Surgery. This study retrospectively reviews the intraoperative and post operative clinical outcomes of Laparoscopic and Robotic Assisted Surgery at U.C. Davis Medical Center to: 1) establish the role of robotics in laparoscopic surgery, and 2) to assess the learning curve by surgeons.
Study Type
Observational
Primary Outcome
Comparing hernia rates between multi-port verses single port approaches.
Condition
Cholecystitis
Intervention
Cholecystectomy
Study Arms / Comparison Groups
Cholecystitis
Description: Patients consented for robotic assisted cholecystectomy evaluated in study.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
200
Start Date
June 2004
Completion Date
March 3, 2017
Primary Completion Date
March 3, 2017
Eligibility Criteria
Inclusion Criteria: - Patients that have undergone robotic assisted laparoscopic cholecystectomy Exclusion Criteria: - Patients under the age of 18, or not choosing to have surgery.
Gender
All
Ages
18 Years - 65 Years
Accepts Healthy Volunteers
No
Contacts
Tamas Vidovszky, MD, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT03059745
Organization ID
237231
Responsible Party
Sponsor
Study Sponsor
University of California, Davis
Study Sponsor
Tamas Vidovszky, MD, Principal Investigator, University of California, Davis
Verification Date
June 2019